Skip to Content

LIBRAX ICN LIBRAX ICN (Chlordiazepoxide Hydrochloride and Clidinium Bromide 5 mg / 2.5 mg)

Pill with imprint LIBRAX ICN LIBRAX ICN is Green, Capsule-shape and has been identified as Chlordiazepoxide Hydrochloride and Clidinium Bromide 5 mg / 2.5 mg. It is supplied by Oceanside Pharmaceuticals, Inc..

Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LIBRAX ICN LIBRAX ICN

Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg LIBRAX ICN LIBRAX ICN

Chlordiazepoxide Hydrochloride and Clidinium Bromide

Imprint
LIBRAX ICN LIBRAX ICN
Strength
5 mg / 2.5 mg
Color
Green
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Anticholinergics/antispasmodics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Oceanside Pharmaceuticals, Inc.
National Drug Code (NDC)
68682-0409

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.